The insulin-like growth factor-I receptor (IGF-IR) activation mediates cell proliferation and prevents apoptosis. It also has other important cellular effects, mediated by downstream signaling pathways. A. IGF-1R activation stimulates cell cycle progression and plays a role in DNA repair. IGF-1R activation stimulates the expression of 14-3-3 sigma a protein previously considered to regulate cell cycle G2/M arrest. MCF-7 cells were studied and the level of 14-3-3 sigma was reduced using siRNA which led to a delay in S phase of the cell cycle in IGF-1-treated cells, suggesting that 14-3-3 sigma is a mediator of the IGF-1-induced cell cycle proliferation. B. Using microarray technology we have demonstrated that IGF-IR activation in NIH-3T3 fibroblast, specifically increases gene expression of a number of genes. Two of these genes, Twist and TDAG51, were not previously known to be influenced by IGF-I. Furthermore our studies using antisense and siRNA technologies demonstrated that reduced levels of these two proteins led to a reduction in IGF-I-induced anti-apoptosis, suggesting that not only are they expressed by IGF-I but they are important in the IGF-I signaling pathways. Future studies will determine the signaling cascades involved in these processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK055017-06
Application #
6983993
Study Section
(CEB)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2004
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code